Concepedia

Publication | Open Access

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

DOIFull Paper Access

1.8K

Citations

24

References

2005

Year

Timothy Winton, Robert B. Livingston, David C. Johnson, James R. Rigas, Michael Johnston, Charles Butts, Yvon Cormier, Richard Inculet, Eric Vallières, Willard A. Fry,
New England Journal of Medicine

Abstract

Adjuvant vinorelbine plus cisplatin has an acceptable level of toxicity and prolongs disease-free and overall survival among patients with completely resected early-stage non-small-cell lung cancer.

References

YearCitations

Page 1